Genexine, Inc. (KOSDAQ:095700)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,860.00
+225.00 (4.85%)
Apr 10, 2026, 3:30 PM KST

Genexine Revenue

Genexine had revenue of 2.07B KRW in the quarter ending March 31, 2024, with 199.63% growth. This brings the company's revenue in the last twelve months to 5.81B, down -3.50% year-over-year. In the year 2023, Genexine had annual revenue of 4.43B, down -72.57%.

Revenue (ttm)
5.81B
Revenue Growth
-3.50%
P/S Ratio
38.06
Revenue / Employee
67.53M
Employees
86
Market Cap
221.03B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20234.43B-11.71B-72.57%
Dec 31, 202216.14B-20.69B-56.18%
Dec 31, 202136.83B18.28B98.61%
Dec 31, 202018.54B7.24B64.06%
Dec 31, 201911.30B5.05B80.80%
Dec 31, 2012 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro
Dec 31, 2010 Pro Pro Pro
Dec 31, 2009 Pro Pro Pro
Dec 31, 2008 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
EASY BIO,Inc.476.94B
Bioneer330.11B
Macrogen195.27B
BINEX168.47B
GC Cell165.52B
JETEMA,76.90B
HLB Therapeutics69.56B
Amicogen41.98B
Revenue Rankings